O2h Ventures Limited

Incubator, Accelerator · Cambridge (United Kingdom)

Incubator, Accelerator

Pre-Seed

Seed

Healthcare

AI

Sign up free to access full profile and submit your pitch.

About

O2h Ventures is a UK-based investment firm specializing in early-stage biotech therapeutics and AI. It operates the first HMRC-approved Knowledge Intensive EIS fund and an SEIS fund, focusing on drug discovery, life science tools, and incubation through its Mill SciTech Park.

Investment Criteria

Other investors that have backed the same portfolio companies as O2h Ventures Limited. Expand any entry to see the shared portfolio companies.

• SyndicateRoom

  7 shared

  Shared portfolio companies

  • Five Alarm Bio Ltd.
  • Kuano Ltd
  • Metrion Biosciences Ltd
  • Monument Therapeutics Limited
  • Neurofenix Ltd.
  • PharmEnable Limited
  • Spirea Ltd
• ACF Investors

  6 shared

  Shared portfolio companies

  • Atelerix Limited
  • Exonate Limited
  • Kuano Ltd
  • Monument Therapeutics Limited
  • Oxford Drug Design Limited
  • Spirea Ltd
• Martlet Capital

  6 shared

  Shared portfolio companies

  • Aivivo Ltd
  • Exonate Limited
  • Pencil Biosciences Limited
  • PharmEnable Limited
  • Qkine Ltd
  • Repositive Ltd
• Parkwalk Advisor

  6 shared

  Shared portfolio companies

  • CamGene Therapeutics
  • Exonate Limited
  • Neophore Limited
  • PharmEnable Limited
  • PhoreMost Limited
  • Qkine Ltd
• Cambridge Enterprise

  4 shared

  Shared portfolio companies

  • CamGene Therapeutics
  • CardiaTec Biosciences LTD
  • PharmEnable Limited
  • PhoreMost Limited
• Amadeus Capital Partners

  3 shared

  Shared portfolio companies

  • Healx Limited
  • PhoreMost Limited
  • Repositive Ltd
• Future Planet Capital

  3 shared

  Shared portfolio companies

  • CamGene Therapeutics
  • Pencil Biosciences Limited
  • Revolver Therapeutics Limited
• IP Group

  3 shared

  Shared portfolio companies

  • Absynth Biologics Limited
  • Chemai Limited
  • Oxford Drug Design Limited
• Alderley Park Ventures

  2 shared

  Shared portfolio companies

  • Absynth Biologics Limited
  • BiVictriX Therapeutics Limited
• Business Growth Fund

  2 shared

  Shared portfolio companies

  • PhoreMost Limited
  • SOMASERVE LIMITED